Sun Pharmaceutical Industries Ltd, India’s largest drug maker, will sell its two oral solid dosage manufacturing facilities located at Philadelphia and Aurora in the US along with 15 related pharmaceutical products to Frontida BioPharm Inc. for an undisclosed amount.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
